Loading viewer...
conference
Format: PDF conference
Geron held a conference call on June 7, 2024, to discuss the FDA approval of RYTELO (imetelstat), covering prescribing information, U.S. market opportunity, and commercial launch plans. The presentation outlines therapeutic and commercial potential, expected market dynamics, launch timing, and key success factors for RYTELO's market entry.
NASA Small Spacecraft Systems Virtual Institute S3VI 2024
conferenceconference
18 Pages
National Aeronautics and Space Administration (NASA)
conference
10 Pages
Seadrill